Ligand profile
ZINC100936755
Virtual-screening candidate from ZINC.
Bound to: KP13_03545 — Cysteine synthase B
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC100936755- UniProt (similar protein)
P9WP55- Tanimoto
- 0.867
- Target protein
- KP13_03545
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 99.4
- −1 ≤ LogP ≤ 5 3.72
- MW ≤ 500 Da 398.4
- LogP ≤ 5 3.72
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 99.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCN1C(=O)/C(=C/c2ccc(O)c(OC)c2)S/C1=N/c1cccc(C(=O)O)c1CCN1C(=O)/C(=C/c2ccc(O)c(OC)c2)S/C1=N/c1cccc(C(=O)O)c1
InChI=1S/C20H18N2O5S/c1-3-22-18(24)17(10-12-7-8-15(23)16(9-12)27-2)28-20(22)21-14-6-4-5-13(11-14)19(25)26/h4-11,23H,3H2,1-2H3,(H,25,26)/b17-10-,21-20+InChI=1S/C20H18N2O5S/c1-3-22-18(24)17(10-12-7-8-15(23)16(9-12)27-2)28-20(22)21-14-6-4-5-13(11-14)19(25)26/h4-11,23H,3H2,1-2H3,(H,25,26)/b17-10-,21-20+
AXDFRKLZPUHKAN-KQHCDTJNSA-NAXDFRKLZPUHKAN-KQHCDTJNSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL2418505
- Homolog
- P9WP55
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC100936755 →
- ZINC ZINC20 ZINC100936755 →
- UniProt UniProt P9WP55 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC100936755”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03545.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 15
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).